Bacillus thuringiensis produces toxins that target invertebrates, including Caenorhabditis elegans. Virulence of Bacillus strains is often highly specific, such that B. thuringiensis strain DB27 is highly pathogenic to C. elegans but shows no virulence for another model nematode, Pristionchus pacificus. To uncover the underlying mechanisms of the differential responses of the two nematodes to B. thuringiensis DB27 and to reveal the C. elegans defense mechanisms against this pathogen, we conducted a genetic screen for C. elegans mutants resistant to B. thuringiensis DB27. Here, we describe a B. thuringiensis DB27-resistant C. elegans mutant that is identical to nasp-1, which encodes the C. elegans homolog of the nuclear-autoantigenic-sperm protein.
G
enetically tractable model organisms, including the nematode Caenorhabditis elegans, have provided detailed insights into the origin and fundamental principles of immunity. More than a decade of research on C. elegans has yielded a wealth of knowledge about its innate immune response to various pathogens, uncovering multiple signaling pathways critical to C. elegans survival after exposure to pathogens (for reviews, see references 1 to 7). Once activated, these pathways induce the expression of an array of antimicrobial effectors that differ, depending on the pathogen present (8) (9) (10) (11) . A variety of microbes, including bacteria (12) , fungi (13) , viruses (14) , and microsporidia (15) , have been used in C. elegans infection studies, with the main focus on etiological agents of human diseases. In some cases, work on C. elegans has led to the identification of conserved virulence factors of human pathogens (16, 17) .
Among the natural pathogens of C. elegans, Bacillus thuringiensis has been extensively studied and B. thuringiensis likely coexists and coevolves with its host in the natural environment (18) . B. thuringiensis produces a variety of pore-forming toxins (PFTs), called Cry toxins, that target the intestinal cells of insects (19) and nematodes (20) . The ability of some Cry toxins to target C. elegans has been exploited to use this nematode as an in vivo system for studying PFTs (21) , and several C. elegans defense mechanisms against PFTs have been discovered (22) (23) (24) (25) (26) (27) .
Although the C. elegans model has provided invaluable insight into the immune defense against pathogens, a comparative approach with other nematodes would enhance our understanding of the host response to pathogens. One nematode that has been used extensively for comparative studies with C. elegans is Pristionchus pacificus. In contrast to C. elegans, which is often found on compost heaps and rotten fruit (28) , P. pacificus is found in tight association with scarab beetles (29) . Not surprisingly, therefore, these two nematodes show different resistance patterns (30) (31) (32) and transcriptional responses to pathogens (11) . For example, C. elegans dies when fed the human opportunistic bacteria Pseudomonas aeruginosa and Staphylococcus aureus and B. thuringiensis Cry5B toxin, whereas P. pacificus is resistant (20, 30) . Moreover, we have previously shown (31) that out of 768 naturally isolated Bacillus strains, only 20 were pathogenic and show distinct patterns of virulence for C. elegans and P. pacificus. The most extreme difference was seen with regard to B. thuringiensis strain DB27. DB27 kills C. elegans in less than 24 h, representing one of the fastest killers of C. elegans known to date, whereas P. pacificus is resistant to this bacterial strain (31) . Our previous study (31) also indicated that the determinants of B. thuringiensis DB27 virulence for C. elegans and also the mechanisms of C. elegans resistance to this pathogen are unknown. Specifically, we have shown that the bre and daf-2 mutants, which are known to be resistant to B. thuringiensis PFT (22) and other bacterial pathogens (33) , respectively, are as susceptible to B. thuringiensis DB27 as wild-type worms are (31) . These findings suggest that potentially novel mechanisms are required to provide defense against this highly virulent Bacillus strain.
Here, we report a genetic screen for B. thuringiensis DB27-resistant mutants of C. elegans and show that a gene represented by two alleles is identical to the nasp-1 gene C09H10. 6 . Further characterization revealed that the nasp-1 mutant shows a reduced life span and reduced fecundity and is RNA interference (RNAi) deficient. Microarray analysis uncovered an unexpected enrichment of dcr-1-regulated genes in nasp-1 mutants. We explored a potential role for dcr-1 in C. elegans innate immunity and show that dcr-1 allele mutants deficient in microRNA (miRNA) processing, but not those that are only deficient in RNAi, are resistant to B. thuringiensis DB27. Transgenic expression of dcr-1 in nasp-1 mutants can rescue the resistance phenotype of nasp-1 mutants. We identified the collagen-encoding gene col-92 as one of the downstream effectors of nasp-1 and dcr-1. These findings describe NASP-1 as a novel C. elegans innate immunity regulator and identify a previously unknown role for DCR-1 in the C. elegans antibacterial immune response.
MATERIALS AND METHODS
Nematodes and bacterial strains. C. elegans strains were maintained on nematode growth medium (NGM) agar plates with Escherichia coli OP50 as a food source. The following strains were kindly provided by the Caenorhabditis Genetics Center (University of Minnesota): wild-type Bristol (N2), Hawaiian mapping strain (CB4856), DA453 eat-2(ad453), WM49 rde-4(ne301), WM27 rde-1(ne219), CB189 unc-32(e189), BB1 dcrmative recombinants identified a 160-kb region on chromosome II between the markers F38A3 and F37H8. Whole-genome sequencing of btr-1 mutants revealed that both btr-1 alleles contain two identical mutations in the mapping interval, which were found in the gene C09H10.6. For transformation rescue, a 2.3-kb PCR fragment, covering upstream and downstream regions of the C09H10.6 transcript, was amplified from wild-type genomic DNA and injected together with a sur-5::gfp plasmid as a coinjection marker into a btr-1 mutant as described elsewhere (36) .
For dcr-1, dpy-5, and col-92 overexpression, respective transcripts with presumptive regulatory regions were PCR amplified from wild-type genomic DNA, purified, and used for injection together with the sur-5::gfp plasmid as a coinjection marker. For intestine-specific expression, a 3.5-kb cpr-1 promoter fragment was amplified from wild-type DNA and fused with the dcr-1 transcript by using Phusion High-Fidelity DNA polymerase (NEB) according to the manufacturer's instructions. The resulting construct was used for btr-1 microinjection. Reporter gene constructs for gene expression analysis were created by the PCR fusion method as described previously (37) . A nasp-1::GFP (green fluorescent protein) translational reporter was obtained by PCR amplification of the nasp-1 transcript with the presumptive promoter region from wild-type genomic DNA, which in the next step was PCR fused to GFP, which was amplified from the pPD95.75 plasmid. A col-92 transcriptional reporter was generated in the same way, with the exception that only a 1.4-kb col-92 promoter region was fused to GFP. The resulting constructs were purified and used for injection together with the pRF4 plasmid (rol-6). Several independent lines were obtained and tested for all of the transgenic experiments described here.
Mutant identification by whole-genome sequencing. We sequenced a genomic library of the btr-1(tu439) mutant on the Illumina Genome Analyzer II platform and obtained 7,398,278 read pairs (2 ϫ 100 bp). Raw reads were aligned with the C. elegans genome assembly (WS235) by using bwa (version 0.5.9-r16) (38) . After the removal of duplicated reads to exclude false variant calls due to PCR amplification biases, 98.8% of the C. elegans assembly was covered by at least one read, with a genome-wide mean coverage of 15ϫ. Variants were called by using SAMtools (version 0.1.18-r982:295) (39) . In total, we identified 2,092 homozygous base substitutions with a SAMtools quality score of at least 20, of which six variants were located within the 160-kb mapping interval on chromosome II. Filtering for variants with a potential deleterious effect (nonsynonymous substitution, premature stop codons, and mutations near splice sites) could exclude three variants as intergenic and intronic, respectively. Two of the remaining three nonsynonymous substitutions were found to affect the nasp-1 gene (amino acid changes, L53S and D307N), and one substitution at genomic position II:11069603, G to A (WS235), was found to cause an S-to-F amino acid exchange in various alternative transcripts of unc-53. A rescue experiment confirmed that mutations responsible for the phenotype occurred in the nasp-1 gene.
Pumping rate measurement. Pharyngeal pumping was counted for 1 min starting on the first day of adulthood. Worms were placed on B. thuringiensis DB27 plates at 25°C and left undisturbed for 3 h before measurement. All worms remained on food during the period of observation. The eat-2(ad453) mutant, known to have low pumping, was used as a control.
Brood size measurement. Brood size was determined by picking L4 worms (one per plate) and transferring them to fresh plates every 24 h until egg laying ceased. The offspring were counted 2 days after the mothers were removed from the plates. Ten worms were used per strain per experiment, and experiments were repeated twice.
Life span assay. Life span assays were performed on NGM plates containing 0.1-mg/ml 5=-fluorodeoxyuridine (FUDR) to prevent progeny from hatching at 20°C. Plates were seeded with concentrated OP50 and allowed to dry overnight. A synchronized population of L4 worms grown on OP50 was placed onto the plates and scored every 48 h. For col-92 RNAi life span assays, NGM plates containing 50 g/ml carbenicillin, 1 mM isopropyl-␤-D-thiogalactoside (IPTG), and 0.1 mg/ml FUDR were seeded with E. coli HT115 expressing col-92 double-stranded RNA (dsRNA) (experiment) or E. coli HT115 harboring the empty vector (control). A synchronized population of L4 worms grown on col-92 RNAi bacteria or vector-containing bacteria were placed onto the RNAi plates with FUDR and scored every 48 h. Upon depletion of food, worms were transferred to fresh plates. Worms were considered dead when no response to touch was observed. Approximately 100 worms were used per strain per experiment, and experiments were repeated twice.
RNAi. To generate specific gene knockdowns, we used RNAi by feeding nematodes with E. coli expressing dsRNA that is homologous to a target gene. E. coli harboring the empty vector was used as a control. E. coli strain HT115 harboring the appropriate vector was grown in LB broth containing 100 g/ml ampicillin at 37°C overnight. Bacteria were plated onto NGM plates containing 50 g/ml carbenicillin and 1 mM IPTG and allowed to grow overnight at 37°C. Three adult hermaphrodites were placed on each RNAi plate and allowed to lay eggs. These eggs were grown on RNAi plates for 3 days at 22°C to the adult stage before being transferred to plates with B. thuringiensis DB27 for pathogenicity assay. All of the RNAi clones used in this study are part of the RNAi library obtained from Source BioScience UK Limited (Nottingham, United Kingdom). cdc-25 RNAi plates were prepared as described above. However, worms were grown at 25°C to the adult stage. cdc-25.1 encodes a CDC25 phosphatase homolog that affects embryonic viability and is necessary for cell proliferation in the germ line. In brief, gravid worms were laid on cdc-25.1 RNAi plates for 4 h and then transferred to similar plates for an additional 4 h of egg laying. After that, gravid hermaphrodites were removed and eggs were left to hatch and grow in the presence of cdc-25.1 RNAi to produce sterile worms. cdc-25 RNAi by injection was performed as described below. For mom-2 RNAi, three adult hermaphrodites were placed on mom-2 RNAi plates and allowed to lay eggs. These eggs were grown on RNAi plates at 20°C to the adult stage. Single adults were subsequently placed onto freshly prepared mom-2 RNAi plates and allowed to lay eggs for 24 h and then removed from the plates. After 16 h, the total amounts of eggs and hatched larvae were scored and viability was expressed as follows: (number of hatched larvae/total number of eggs) ϫ 100. The mom-2 coinjection experiments were conducted at 20°C as described previously (40) . dsRNA for injection experiments was prepared by in vitro transcription. DNA templates were PCR amplified from plasmids corresponding to the RNAi clones with T7 primers or PCR amplified from C. elegans genomic DNA with gene-specific primers with attached T7 promoters in case the gene is not present in the available RNAi library. PCR products were used for dsRNA synthesis in a single reaction with the TranscriptAid T7 high-yield transcription kit (Thermo Scientific). Concentrations of dsRNAs were determined with a spectrophotometer, and the quality and size of dsRNAs were assessed by gel electrophoresis. Young hermaphrodites were injected in the gonads with 300 to 600 ng/l of dsRNA of the candidate gene. Given that dpy-5 RNAi produces a clear morphological phenotype but has no effect on survival, dpy-5 dsRNA was used as a positive control for injection and as a negative control in survival assays. Adult F 1 worms were used in the pathogen survival assay.
RNA collection for microarray experiments. Synchronized populations of wild-type and tu439 mutant C. elegans worms were obtained by hypochlorite treatment and allowed to grow to the young adult stage on E. coli OP50 at 20°C. Worms were exposed to B. thuringiensis DB27 for 4 h and then picked into TRIzol reagent for RNA extraction. Four biological replicates were collected for each experimental condition and the control condition. For each biological replicate, about 200 young adult hermaphrodites were picked into 1 ml of TRIzol (Invitrogen) and total RNA was extracted according to the manufacturer's instructions and purified further by phenol-chloroform-isoamyl alcohol precipitation. The RNA pellet was suspended in RNase-free water and assessed on a NanoDrop spectrophotometer for quantity and RNA quality.
Microarray experiments and data analysis. Oligonucleotide microarrays for C. elegans containing ϳ43,000 unique probes for ϳ20,000 C. elegans genes were obtained from Agilent Technologies (NCBI GEO accession number GPL10094). All experiments are in a two-color format, where Cy5 and Cy3 dye-labeled cRNAs from experimental and control samples are cohybridized on the same microarray. The four biological replicates per experiment included two dye swap experiments to account for differences in dye labeling. Experimental procedures and data analysis were essentially the same as described before (41) . Microarrays corresponding to three of the four biological replicates passed the quality criteria and were used in the final analysis. Genes with a false-discovery rate (FDR)-corrected P value of Յ0.05 and an absolute fold change greater than or equal to a cutoff of 1.5 on a log 2 scale were called differentially expressed.
Expression cluster enrichment analysis. The list of microarray expression profiles in which a given C. elegans gene is known to be differentially expressed can be extracted from the Expression Cluster section of the WormBase (42) gene summary page for each gene. We retrieved all of the available expression clusters for C. elegans genes from the WormBase website (www.wormbase.org) and used them to identify expression clusters enriched in our expression profile, an approach that we have successfully used previously to analyze genome-wide trends in expression profiles (11, 41) . P values for expression cluster enrichment in each expression profile were computed with a two-by-two Fisher exact test. An FDRcorrected P value cutoff of 0.05 was used as the significance threshold.
qRT-PCR. Synchronized C. elegans worms at the L4 stage were exposed to B. thuringiensis DB27 for 4 h before harvesting. Nematodes were collected by washing plates with M9 buffer, and RNA was extracted with TRIzol reagent. cDNA was synthesized with the SuperScript ⌱⌱⌱ kit (Invitrogen). Quantitative real-time PCR (qRT-PCR) was conducted with the LightCycler 480 SYBR green ⌱ master kit (Roche) on a LightCycler 480 real-time PCR instrument (Roche) in a 96-well format. Relative fold changes in transcripts were calculated by the comparative cycle threshold (C T ) method after normalization to snb-1, which has been used previously in qRT-PCR studies of C. elegans innate immunity (43-45). C T s were determined by the Roche LightCycler software. All samples were run in triplicate. The sequences of the primers used are available upon request.
Statistical analysis. Kaplan-Meier nonparametric comparisons and a log rank test were used for statistical analysis of C. elegans survival in the presence of pathogens and for life span analysis. In each case, curves represent the combined data from at least three independent experiments. Statistical analysis of the difference between two values was performed with Student's t test. Statistical significance was set at P Յ 0.05.
Microarray data accession number. Raw and processed data from all of the experiments described here are available under accession number GSE43905 in the NCBI Gene Expression Omnibus database (http://www .ncbi.nlm.nih.gov/geo/).
RESULTS
Forward genetic screen for B. thuringiensis DB27-resistant (btr) mutants. B. thuringiensis DB27 was isolated from a dung beetle (31) and was selected for detailed investigation because of its high virulence for C. elegans. This strain is 100% lethal in just 16 h under standard assay conditions (Fig. 1A) . Our previous studies indicated that all of the bre and daf-2 mutants tested were as susceptible to B. thuringiensis DB27 as wild-type worms are (31) . In contrast to the observed susceptibility of C. elegans, the second model nematode organism, P. pacificus, is fully resistant to B. thuringiensis DB27 (31) . To uncover a potential resistance mechanism and to better understand the specificity of B. thuringiensis virulence for certain nematode species, we conducted a forward genetic screen for mutants of C. elegans with strong resistance to B. thuringiensis DB27. Specifically, we screened for mutants that would extend C. elegans survival on monoxenic cultures of B. thuringiensis DB27 by at least a factor of 3, in order to select for major effectors. From 1,800,000 EMS-mutagenized gametes, we isolated three btr (B. thuringiensis-resistant) mutants that exhibited strong resistance to B. thuringiensis-mediated killing (Fig. 1B) . Complementation tests revealed that these mutants fall into two complementation groups (data not shown) with two alleles (tu439 and tu440) of a locus provisionally named btr-1 and a single allele (tu438) of a second locus called btr-2. Here we further characterize btr-1.
btr-1(tu439) mutants are resistant to additional pathogens and have a reduced life span. Considering that several pathogenresistant C. elegans mutants are resistant to multiple pathogens (33), we exposed btr-1(tu439) mutant worms to additional pathogens to further characterize the specificity of the mutant. We found that tu439 mutants exhibited stronger resistance to the Gram-positive pathogen S. aureus than wild-type worms did (Fig.  1C) . In contrast, tu439 mutants showed wild-type survival on the Gram-negative pathogens P. aeruginosa and S. marcescens ( Fig. 1D and E). These results indicate that tu439 confers resistance to two, but not all, of the pathogens tested.
To explore additional functions, we tested several physiological parameters of tu439 mutant worms. First, we estimated the pumping rate as an indirect measurement of bacterial uptake to elucidate bacterial consumption. The pumping rate of the tu439 mutant on DB27 is similar to that of the wild type, whereas the control eat-2(ad453) mutant shows the expected reduction of pumping in our assay system ( Fig. 2A) . Thus, pharyngeal pumping is unaffected, suggesting that pathogen consumption is not reduced in mutant worms. To rule out the possibility that bacteria might persist in the intestines of wildtype but not mutant worms, we fed worms with DB27 for 4 h, which is sufficient to observe accumulation of bacteria in the gut (see Fig. S1A in the supplemental material). We then shifted the worms to OP50 for 2 h and measured the DB27 CFU. Neither the wild-type nor the mutant worms showed a difference in their DB27 CFU counts after the shift to OP50, suggesting that the persistence of DB27 is not extended in wildtype worms (see Fig. S1B ). Second, we observed that tu439 mutants exhibit reduced fertility (see Fig. S1C ). A similar phenotype was also annotated for other pathogen-resistant mu- tants (46) (47) (48) and suggests that there is a tradeoff between reproduction and an elevated immune response. This raises the possibility that tu439 confers increased resistance to B. thuringiensis DB27 because of diminished fecundity.
To elucidate this further, we assessed the survival of sterile mutants exposed to B. thuringiensis DB27. First, we investigated fecundity in combination with matricidal internal hatching of eggs by comparing the survival of wild-type worms to that of fer-1 and fer-15 mutants (47) . fer mutants have a germ line but do not suffer from matricidal effects due to the lack of fertilization since their sperm production is affected (49) . Both fer mutants are as susceptible to B. thuringiensis DB27 as wild-type worms are, suggesting that matricidal hatching of eggs does not contribute to B. thuringiensis DB27 killing and that increased resistance of tu439 to DB27 is not due to a lack of matricide (Fig. 2B ). This finding is further supported by the fact that males are susceptible to DB27 (not shown).
In a second set of experiments, we used cdc-25 RNAi, which also causes sterility. cdc-25 RNAi led to enhanced survival of wildtype worms exposed to B. thuringiensis DB27 (Fig. 2C) . However, cdc-25 RNAi in a tu439 background resulted in a significant increase in resistance to DB27 that was stronger than the resistance of single tu439 mutant or wild-type cdc-25 RNAi worms (Fig. 2C) . The cumulative effect of the two mutations suggests that the underlying molecular mechanisms are independent and that tu439-mediated resistance to B. thuringiensis DB27 is not due simply to reduced fecundity. Additionally, in contrast to sterile mutants, the tu439 mutant is not resistant to S. marcescens and P. aeruginosa ( Fig. 1D and E) . Finally, we measured the life span of tu439 mutants, given that life span extension often correlates with increased pathogen resistance in C. elegans (33, 47) . Interestingly, we found that tu439 mutants fed on E. coli OP50 show a slight but significant life span reduction in comparison to wild-type worms (Fig. 2D) . These results show a novel relationship between life span and immunity and suggest that tu439 mutant worm resistance to bacterial infection is not a simple consequence of extended longevity. Taken together, tu439 mutant worms are resistant to several Gram-positive bacteria, have a reduced life span and fecundity, and show that immunity can be mechanistically uncoupled from aging.
btr-1 is identical to the C. elegans nasp-1 gene. To clone tu439, we used RFLP-SNP mapping (35) and next-generation sequencing (50) . In brief, we mapped btr-1 to an approximately 160-kb region on chromosome II between the markers F38A3 and F37H8. Whole-genome sequencing of both alleles revealed mutations in the C09H10.6 gene, which has been described as the C. elegans homolog of the gene for human nuclear-autoantigenicsperm protein (nasp-1) (Fig. 3A) . nasp-1 has previously been implicated in C. elegans female development (51) .
Interestingly, the two alleles appear to contain two identical mutations, which might be due to the fact that they were derived from a single mother. The first mutation is a T-to-C substitution in the second exon of C. elegans nasp-1 resulting in a leucine-toserine substitution at amino acid position 53, whereas the second mutation (a G-to-A change in exon 3) leads to a substitution from aspartic acid to asparagine at amino acid position 307 (Fig. 3A) . To confirm that the resistance phenotype of tu439 is due to these mutations in C09H10.6, we performed rescue and RNAi experiments. First, transgenic expression of a wild-type copy of C09H10.6 under the control of its endogenous promoter in the tu439 mutant background resulted in almost complete restoration of wild-type susceptibility to B. thuringiensis DB27 (Fig. 3B ) and S. aureus (Fig. 3C) . Additionally, transgenic expression of C09H10.6 partially rescued the diminished reproduction of the tu439 mutant (not shown). Second, C09H10.6 RNAi increases nematode resistance to B. thuringiensis DB27 (Fig. 3D ) and S. aureus (Fig.  3E ) in a way similar to that of tu439, providing additional evidence that the mutant is allelic to C09H10.6. Also, we noticed that nasp-1 RNAi worms have slower growth and less fecundity at 25°C than vector-treated worms. The high conservation of the amino acids that were mutated (see Fig. S2 in the supplemental material), especially D307, suggests that our nasp-1 mutant is a strong reduction-of-function allele. Also, the similarity between the nasp-1 RNAi and the mutant phenotype suggests that the isolated alleles represent reduction-of-function rather than neomorphic mutations. In summary, we conclude that btr-1(tu439) is identical to the nasp-1-like gene C09H10.6. Following standard C. elegans nomenclature rules, we rename btr-1 as nasp-1. The survival on a lawn of B. thuringiensis DB27 of wild-type worms grown on dsRNA for C09H10.6, which corresponds to tu439, is significantly (P Ͻ 0.0001) greater than that of worms grown on dsRNA as a vector control. (E) The survival on a lawn of S. aureus of wild-type worms grown on dsRNA for C09H10.6, which corresponds to tu439, is significantly (P Ͻ 0.001) greater than that of worms grown on dsRNA as a vector control. The data shown are means Ϯ the standard errors of the means. For each condition in survival assays, 60 to 80 worms (20 per plate) were used for each of multiple independent biological replicates.
The p38 MAPK pathway is required for the nasp-1 mutant's resistance. Next, we searched for potential interactions of nasp-1 with known pathogen response regulators to further explore its biological role. First, we tested the p38 mitogen-activated protein kinase (MAPK) pathway (52) by performing injection of pmk-1 dsRNA into a nasp-1 mutant background. After pmk-1 depletion, the resistance of the nasp-1 mutant to B. thuringiensis DB27 is completely abolished, even below the wild-type level (Fig. 4A) . Similarly, overactivation of PMK-1 by vph-1 RNAi (53) strongly increased the survival of C. elegans on B. thuringiensis DB27 (Fig.  4A) . In contrast, injection of dpy-5 as a control dsRNA had no effect on the survival of wild-type and nasp-1 mutant worms, although it did result in a dpy phenotype (Fig. 4A) . Together, these results suggest that the effects of pmk-1 and vhp-1 on survival are gene specific and that nasp-1 potentially may function in parallel with the p38 MAPK pathway. In contrast, RNAi of daf-16, another C. elegans innate immunity regulator (33), had no effect on the nasp-1 mutant's resistance to B. thuringiensis DB27 (Fig. 4A) , indicating that nasp-1 does not confer resistance to B. thuringiensis DB27 by acting through daf-16/FOXO. This result also provides an additional argument that the nasp-1 mutant's resistance is independent of reproduction, because increased pathogen resistance of most of the sterile mutants requires daf-16 (47) .
nasp-1 mutants are deficient for RNAi by feeding. When performing the RNAi experiments described above, we noticed that a knockdown of genes by RNAi in a nasp-1 mutant background was only possible by injection of dsRNA, suggesting that the nasp-1 mutant exhibits a sid phenotype (54) . In contrast, RNAi by feeding in the nasp-1 mutant background did not have the same effect (Fig. 4B) . Specifically, pmk-1 RNAi by feeding did not change the nasp-1 mutant's resistance phenotype, whereas pmk-1 RNAi by injection abolished the nasp-1 mutant's resistance to B. thuringiensis DB27 completely (Fig. 4B) . Similarly, we observed that dpy-5 RNAi by injection resulted in a dpy phenotype in a nasp-1 mutant background, whereas dpy-5 RNAi by feeding did not (data not shown). These observations provide first evidence that nasp-1 mutants might be defective in their RNAi response; however, they do not exhibit a complete rde phenotype but rather show similarity to sid mutants.
To further explore this phenotype, we fed nasp-1 mutants with E. coli expressing dsRNA against mom-2, a gene essential for viability (40, 55) . Almost no viable progeny were obtained from wild- . daf-16 knockdown upon RNAi by injection has no effect on nasp-1 mutant (P Ͼ 0.05 for nasp-1;dpy-5 versus nasp-1;daf-16 mutant worms) resistance to B. thuringiensis DB27. vhp-1 RNAi significantly (P Ͻ 0.0001) increases the survival of wild-type worms on a lawn of B. thuringiensis DB27 compared to control dpy-5 RNAi, which was used as a positive control for injection and as a negative control in a survival assay (see Materials and Methods). (B) pmk-1 knockdown upon RNAi by feeding has no effect on nasp-1-mediated resistance to B. thuringiensis DB27 (P Ͼ 0.05), while pmk-1 knockdown upon RNAi by injection abolishes the resistance of the nasp-1 mutant (P Ͻ 0.0001). The data shown are means Ϯ the standard errors of the means. For each condition in survival assays, 60 to 80 worms (20 per plate) were used for each of multiple independent biological replicates. (C) nasp-1 mutant is RNAi deficient. Wild-type and nasp-1 and rde-4 (positive control) mutant worms and nasp-1 rescuing line worms were fed E. coli expressing dsRNA of mom-2, which is essential for viability. Viability was assessed as the proportion of hatched larvae relative to the total number of eggs laid. Both rde-4 and nasp-1 mutants show significantly (P Ͻ 0.0001) higher survival of progeny than the wild type, indicating that both mutants are resistant to RNAi-mediated mom-2 lethality. nasp-1 overexpression restores the nasp-1(tu439) mutant's susceptibility to mom-2-mediated lethality. The data shown are means Ϯ the standard errors of the means. (D) Wild-type hermaphrodites were coinjected with each candidate dsRNA and mom-2 dsRNA. rde-1 RNAi was used as a positive control, while unc-32 RNAi was used as a negative control. nasp-1 RNAi significantly increases F 1 viability (P Ͻ 0.0001) relative to that of the negative control or mom-2 RNAi alone. The data shown are means Ϯ the standard errors of the means. type worms, whereas nearly 80% of the nasp-1 mutant progeny survived mom-2 RNAi by feeding (Fig. 4C) . Transgenic expression of nasp-1 under the control of its endogenous promoter in the tu439 mutant background resulted in almost complete restoration of the wild-type response to mom-2-mediated lethality. rde-4 mutants, which are known to be RNAi deficient, were used as a control and showed nearly 100% viability (Fig. 4C) . Additionally, we coinjected wild-type worms with dsRNA of mom-2 and/or dsRNA of nasp-1 or control dsRNA and scored the viability of the progeny. The survival of progeny indicates that RNAi against nasp-1 enables worms to overcome the lethality of mom-2 RNAi (Fig.  4D ). Worms coinjected with dsRNA of a positive-control gene, rde-1, showed 97% survival, indicating strong protection from mom-2 lethality by rde-1 RNAi. Coinjection with dsRNA of unc-32 or other genes dispensable for RNAi resulted in a very low survival rate. In contrast, coinjection of nasp-1 dsRNA significantly rescued the lethality caused by mom-2 dsRNA. Thus, in contrast to RNAi mutants, such as rde-1 RNAi mutants, that are resistant to RNAi independently of the delivery method (56), nasp-1 mutants are still able to perform RNAi when dsRNA is injected into the germ line. In this, they are similar to sid mutants (54) , suggesting that they function primarily in the uptake or spreading of dsRNA rather than in modulation of the core RNAi machinery.
To provide further insight into this phenotype, we generated transgenic worms expressing a nasp-1-encoded translational protein fusion with GFP to study the site of action of nasp-1. Interestingly, expression was localized primarily in the pharynx (see Fig.  S3 in the supplemental material). Expression was seen in the metacorpus and terminal bulb of the pharynx with a clear intracellular localization. Given that the pharynx is exposed to pathogens, this observation further supports the idea that nasp-1 functions in innate immunity; however, the link to the sid phenotype remains unknown. Taken together, these results support the observation that nasp-1 is required for a robust RNAi response.
The transcriptional response of nasp-1 mutants to B. thuringiensis DB27 reveals a strong overlap with dcr-1 mutants. To identify genes differentially regulated in nasp-1 mutants when they are exposed to B. thuringiensis DB27, we used whole-genome microarrays on an Agilent platform. Microarray analysis revealed that differential expression in nasp-1 mutants mostly resulted in downregulation (247 genes), whereas only 31 genes were more strongly expressed in nasp-1 mutants than in wild-type worms (see Data Set S1 in the supplemental material, FDR-corrected P value of Յ0.05, fold change cutoff of 1.5 on a log 2 scale). We validated these results by selecting a total of 12 down-and upregulated genes and confirmed their expression by qRT-PCR (Fig. 5A) . Interestingly, 58 of the 247 downregulated genes were previously identified as genes that are induced by B. thuringiensis DB27, in comparison to OP50, in wild-type worms (11) (Fig. 5B) . These results, together with the finding that most expression changes in nasp-1 mutants result in transcriptional repression, suggest that NASP-1 normally acts as an activator of transcription.
Surprisingly, further characterization of downregulated genes in nasp-1 mutants revealed a highly significant overlap with genes regulated by different components of the RNAi machinery (57), such as rde-4, rde-3, and rrf-1 (see Fig. S4 in the supplemental material). The most significant enrichment was found for genes previously annotated as targets of the only C. elegans dicer gene, dcr-1. Specifically, 116 of the 247 nasp-1-repressed genes were previously identified as dcr-1-regulated genes (Fig. 5C ). This strong overlap is further supported by quantitative PCR experiments showing that dcr-1 expression is itself reduced in nasp-1 mutants compared to that in the wild type (Fig. 5A) . These findings are consistent with the reduced life span and RNAi deficiency of nasp-1 mutants (see above). Thus, an intriguing possibility is that repression of DCR-1 function is responsible for the increased pathogen resistance observed in nasp-1 mutants.
dcr-1 is involved in innate immunity through its role in miRNA processing. The unexpected correlation between downregulated genes in nasp-1 and dcr-1 mutants encouraged us to look for further interactions between these two loci. We hypothesized that if reduced DCR-1 function in nasp-1 mutants were responsible for their increased resistance to B. thuringiensis DB27, dcr-1 mutants should also be more resistant to the pathogen. Indeed, when we tested several dcr-1 alleles, we found that the mutant for presumptive null allele dcr-1(ok247) showed greater survival on B. thuringiensis DB27 than the wild type (Fig. 6A) . This is unlikely to be due to altered reproduction because the dcr-1(ok247) mutant is not resistant to S. marcescens (see Fig. S5A in the supplemental material) and P. aeruginosa (see Fig. S5B ) and exhibits a reduced life span (58) , in contrast to sterile mutants (59, 60) . As the dcr-1(ok247) deletion allele was marked with a recessive allele of unc-32 to facilitate the isolation of dcr-1(ok247) homozygous worms (57) and considering that the unc-32 mutant was shown to have increased resistance to Erwinia carotovora and Photorhabdus luminescens (8), we also tested the survival of unc-32 mutants on B. thuringiensis DB27 and found that they have a wildtype response to the pathogen (Fig. 6A) . Furthermore, transgenic expression of dcr-1 in a dcr-1(ok247) mutant restored wild-type susceptibility to B. thuringiensis DB27 (Fig. 6A) . Together, these findings indicate a novel role for dcr-1 in innate immunity to the pathogen B. thuringiensis DB27.
Interestingly, the effect of dcr-1 on pathogen resistance is allele specific. We found that survival on B. thuringiensis DB27 was unchanged in the mutant with the activating dcr-1(mg375) allele (Fig. 6A) . The dcr-1(mg375) allele has an impaired helicase domain and small interfering RNA (siRNA) production and, consequently, enhanced RNAi, whereas miRNA synthesis is intact (61) . To further test the idea that resistance to B. thuringiensis DB27 is associated with altered miRNA processing, we investigated the effects of the rde-4 and rde-1 mutations on pathogen survival. rde-1 and rde-4 play a role in RNAi but not in miRNA processing (57) , and they were shown to produce a reduced life span but normal survival on S. marcescens, although the immune response is upregulated (57) . Indeed, rde-1 and rde-4 mutants did not show increased resistance to B. thuringiensis DB27 (Fig. 6B) . In contrast, mutants with changes in the drsh-1 and alg-1 genes, which are involved in miRNA processing (62, 63) , but not in RNAi, exhibited increased resistance to B. thuringiensis DB27 (Fig. 6C) . To prove that the resistance of drsh-1 and alg-1 mutants is not due to impaired germ line development and fertility, we rendered both mutants sterile via cdc-25 RNAi and compared their survival to that of control vector-treated worms. The survival of alg-1 mutants was significantly increased after cdc-25 RNAi compared to that of vector-treated alg-1 mutants and compared to wild-type worms treated with either the empty vector or cdc-25 RNAi (Fig.  6D) , indicating that alg-1 and cdc-25 mutants exhibit resistance via distinct mechanisms and that alg-1-mediated resistance to B. thuringiensis DB27 is not simply a consequence of altered fertility. However, we did not observe any differences in survival between drsh-1 vector-and drsh-1 cdc-25 RNAi-treated worms (Fig. 6E) , suggesting that the increased resistance of drsh-1 mutants to B. thuringiensis DB27 is indeed a secondary effect of sterility. Taken together, these results suggest that the impairment of DCR-1 function in miRNA processing confers resistance to B. thuringiensis DB27. Furthermore, these data, together with the downregulation of dcr-1 expression in nasp-1 mutants, support the conclusion that the resistance of nasp-1 mutants is due to reduced DCR-1 activity.
nasp-1 acts through DCR-1/Dicer. The experiments described above are consistent with the hypothesis that dcr-1 is genetically downstream of nasp-1. This conclusion is further supported by previous expression profiling of dcr-1 mutants, which did not show any change in the expression of nasp-1 in dcr-1 mutants (57) . To further test this hypothesis, we investigated whether overexpression of dcr-1 would abolish the increased resistance of the nasp-1 mutant to B. thuringiensis DB27. Indeed, dcr-1 overexpression under the control of its endogenous promoter significantly reduced the survival of nasp-1 mutant worms on B. thuringiensis DB27 (Fig. 6F) . Additionally, dcr-1 overexpression restored the reduced life span of nasp-1 mutants (see Fig. S6 in the supplemental material). Given that C. elegans dcr-1 is expressed at high levels in the intestine (58) , which is also the major site of infection by ingested pathogens, we investigated whether upregulation of dcr-1 specifically in the intestine could affect the nasp-1 mutant's pathogen resistance. When we overexpressed dcr-1 under the control of the intestine-specific cpr-1 promoter, we noticed a significant decrease in the nasp-1 mutant's survival on B. thuringiensis DB27 (Fig. 6F) . Thus, the previously unknown role of DCR-1 in C. elegans innate immunity is genetically downstream of nasp-1 and acts through the C. elegans intestine.
NASP-1 and Dicer resistance to S. aureus is due to impaired fecundity. Considering that the nasp-1 mutant shows increased resistance to S. aureus, we investigated whether it is also mediated by the same mechanism that is employed in the defense against B. thuringiensis DB27. Given that the nasp-1 mutant has reduced fecundity, a common feature of S. aureus-resistant mutants (47), we first tested if the nasp-1 mutant's resistance to S. aureus depends on reproduction. As shown in Fig. 7A , nasp-1 mutants injected with cdc-25 interfering dsRNA survived S. aureus exposure longer than control-injected worms. However, their survival was similar to that of wild-type worms injected with cdc-25 interfering dsRNA (Fig. 7A) . Thus, nasp-1 mutants do not have an additive effect with cdc-25 RNAi for S. aureus resistance, as is the case for B. thuringiensis DB27 (Fig. 2C) . These findings suggest that nasp-1 and cdc-25 RNAi increase resistance to S. aureus via the same mechanism and the nasp-1 mutant's resistance to S. aureus is very likely due to partial sterility. In contrast, nasp-1 and cdc-25 RNAi function in independent pathways for B. thuringiensis DB27 resistance (Fig. 2) .
This difference between S. aureus and B. thuringiensis DB27 was further explored by studying the allele specificity of Dicer mutants. There was no allele specificity in terms of Dicer resistance to S. aureus since both dcr-1(ok247) and dcr-1(mg375) mutant worms were more resistant to S. aureus than wild-type worms were (Fig. 7B) . Also, dcr-1 mutant resistance can be rescued by transgenic overexpression of dcr-1 under the control of its endogenous promoter (Fig. 7B) , indicating that Dicer might play a role in the C. elegans defense against S. aureus. Considering the reproductive defects of dcr-1 mutants, which may contribute to increased resistance to S. aureus, we used cdc-25 RNAi to sterilize dcr-1(mg375) mutant worms. The survival of mg375 mutant worms was greater than that of vector-treated worms but was not significantly different from that of wild-type worms treated with cdc-25 RNAi, indicating the absence of a cumulative effect of dcr-1 and cdc-25 (Fig. 7C) . Thus, the dcr-1 mutant's resistance to S. aureus is due to diminished reproduction, as in the case of the nasp-1 mutant. We also assessed the survival of RNAi-and miRNA-deficient mutants on S. aureus. Both rde-1 and rde-4 mutants showed a wild-type response to S. aureus (Fig. 7D) . The alg-1 mutant, which has increased survival on B. thuringiensis DB27, exhibited survival similar to that of the wild type on S. aureus (Fig.  7D) , while only the drsh-1 mutant was more resistant to S. aureus infection (Fig. 7D) . However, as in the case of B. thuringiensis DB27, the increased resistance seen is the consequence of sterility since cdc-25 RNAi did not further increase the survival of drsh-1 mutants (Fig. 7E) . Taken together, these results show that the nasp-1 mutant's resistance to S. aureus is very likely due to impaired fecundity and at this stage it is impossible to disconnect immune and reproductive mechanisms that confer the nasp-1 mutant's resistance to S. aureus.
The collagen gene col-92 acts downstream of nasp-1 and confers resistance to DB27. Finally, we wanted to uncover the molecular mechanisms of nasp-1-and dcr-1-mediated resistance to B. thuringiensis DB27. For this, we hypothesized that the repression of dcr-1 activity in nasp-1 mutants leads to overactivation of effec- tor genes, which make C. elegans more resistant to infection. Consistent with this idea, we found that several B. thuringiensis DB27-responsive genes are more strongly expressed in nasp-1 and dcr-1 mutants than in the wild type (Fig. 8A) . To test this hypothesis further, we used RNAi to knock down nasp-1-upregulated genes individually (see Data Set S1 in the supplemental material) in the nasp-1 mutant background. While the knockdown of the majority of these genes resulted in no obvious effect on nasp-1-mediated resistance (see Fig. S7 in the supplemental material), col-92 RNAi produced significant suppression of nasp-1-mediated resistance to DB27 ( Fig. 8B; see Fig. S7 ) and S. aureus (Fig. 8C) . Furthermore, knockdown of col-92 in wild-type worms makes them hypersusceptible to B. thuringiensis DB27 (Fig. 8D) , S. aureus, and P. aeruginosa (see Fig. S8A and B) but not to S. marcescens (see Fig.   S8C ). However, the life span of col-92 RNAi worms was not affected (see Fig. S8D ), suggesting that its hypersusceptibility to bacterial infection is not a result of impaired fitness. In contrast, col-92 overexpression under the control of its endogenous promoter increases resistance to B. thuringiensis DB27 (Fig. 8E) and S. aureus (see Fig. S8E ) infections. At the same time, overexpression of dpy-5, used as a control, resulted in no obvious effects on resistance to B. thuringiensis DB27 (Fig. 8E) and S. aureus (see Fig.  S8E ). Moreover, dpy-5 RNAi and col-93 RNAi had no effect on C. elegans survival upon exposure to B. thuringiensis DB27, indicating that the effect of col-92 is specific and is unlikely to be due only to simple alteration of cuticle structure.
To shed more light on the immune function of col-92, we studied the expression of the gene. It should be noted that COL-92 is a member of a nematode-specific family of collagens, characterized by a cuticle collagen N-terminal domain. Transgenic lines harboring a col-92-GFP transcriptional fusion construct showed that the gene is expressed predominantly in the hypodermis (see Fig. S9 in the supplemental material). Therefore, although col-92 is a downstream target of NASP-1, its immune function awaits further characterization and might be associated with cuticle. Thus, the previously uncharacterized collagen gene col-92 plays a pivotal role in the C. elegans defense against bacterial infection and represents a downstream target of NASP-1 and DCR-1.
DISCUSSION
In this study, we isolated a B. thuringiensis DB27-resistant mutant in C. elegans that we showed to be identical to nasp-1, a gene that has previously been implicated in female development (51) . Both nasp-1 alleles are reduction-of-function but not null alleles. Further characterization of nasp-1 helped to discover a previously unknown function of dcr-1/Dicer in the immune response of C. elegans. Mammalian NASP1 is a tetratricopeptide (TPR) repeat domain-containing H1 linker histone binding protein that is part of a multichaperone complex implicated in nucleosome remodeling (64, 65) . NASP1 is highly expressed in dividing cells and is required for normal cell cycle progression (65) . A role for C. elegans nasp-1 in chromatin remodeling is supported by its interactions with a variety of chromatin-remodeling proteins like linker H1 histones and histone deacetylase (51) . We hypothesize that nasp-1 might regulate the pathogen response of C. elegans via transcription and chromatin-remodeling mechanisms. Strikingly, it was shown that changes in NASP1 expression lead to the misregulation of a variety of genes in HeLa cells, including genes involved in the immune responses (66) .
The RNAi deficiency of C. elegans nasp-1 is similar to that of other chromatin-remodeling genes (40) and provided the entry point for the discovery of the function of dcr-1 in C. elegans innate immunity, the most unexpected finding of this study. DCR-1 is an RNase ⌱⌱⌱ endoribonuclease whose primary function is the cleavage of dsRNA into smaller fragments that mediate RNAi (67) . DCR-1 is required for miRNA processing and the synthesis of endo-siRNAs implicated in gene silencing and epigenetic regulation (67) (68) (69) . Previous studies have shown a role for DCR-1 and the RNAi machinery in the C. elegans response to viral infections (14, 70) . However, our results point toward a broader function of Dicer in innate immunity. To our knowledge, this study is the first to show a direct role for DCR-1 in antibacterial immunity. Results obtained by using different mutant alleles of C. elegans dcr-1 support the conclusion that its function in pathogen defense is mediated primarily by impaired miRNA biogenesis. Further evidence for this conclusion comes from the analysis of other genes that allow discrimination between miRNA processing and RNAi. Consistent with our conclusion is a recent report showing that miRNA activity in the C. elegans intestine is largely dedicated to attenuating the activity of pathogen response genes (48) . Specifically, Kudlow et al. (48) have shown that ain-1 mutants, which have altered miRNA-induced silencing complex activity, are more resistant to P. aeruginosa than wild-type worms are. Additionally, those authors were able to identify specific miRNA families that are involved in damping of the immune response in the absence of infection. Together, these findings suggest that intestinal miRNAs act as negative regulators of infection response genes. However, we have been unable to identify a miRNA or siRNA that is likely to be a part of the mechanisms of nasp-1-mediated resistance to B. thuringiensis DB27. Such studies might be complicated by the fact that redundancy among small RNAs is a well-known phenomenon in C. elegans.
The increased resistance of dcr-1 mutants to B. thuringiensis DB27 might be due to the upregulation of pathogen response genes. Indeed, our RT-PCR experiment showed induction of some of the B. thuringiensis DB27-responsive genes in dcr-1 mutants (Fig. 8A) , indicating that DCR-1 may function as a suppressor of the C. elegans immune response to B. thuringiensis DB27 via suppression of miRNA synthesis. By using a reverse genetic approach, we found that one of the nasp-1-upregulated genes, namely, col-92, is an important determinant of the nasp-1 mutant's resistance that acts downstream of nasp-1 and dcr-1. Collagens are differentially expressed in response to a variety of microbes (8, 71) , suggesting that they may represent an essential part of the immune response. Nematodes, including C. elegans, are known for the unusually high number of collagens encoded in their genomes, and collagens have been implicated in life span and immunity (71) (72) (73) (74) . A potential role for collagens in the immune response might be in part responsible for the high number of nematode collagens, although direct proof of this assumption is hard to provide, even in the age of reverse genetics. One phenomenon that might hinder the identification of specific functions of collagens is redundancy, which is often seen among structurally related genes (73) .
Our findings on the role of DCR-1 in C. elegans innate immunity strongly correlate with the identification of Dicer as a regulator of the mammalian immune response. Tang and coworkers found that the inhibition of Dicer in human cells upregulates major histocompatibility complex class ⌱-related molecules A and B, which are innate immune system ligands for the NKG2D receptor expressed by natural killer cells (75) . Those authors proposed further that a Dicer knockdown is indirectly linked to human innate immunity via the DNA damaging pathway. Whether a similar DNA-damaging pathway is involved in the upregulation of the C. elegans innate immune response awaits further analysis. Additionally, various miRNAs have been implicated in the regulation of diverse aspects of human innate immunity (76) , including direct microbial killing. For example, miR-223-deficient neutrophils were shown to kill Candida albicans more effectively then wildtype cells do (77) . A role for miRNAs in the human immune system is further supported by evidence that many immunological diseases are caused by alteration of miRNA function (76) . Therefore, Dicer and miRNAs might play a conserved role as negative regulators in immunity.
Although alterations of dcr-1 or miRNA functions are beneficial to C. elegans under pathogenic conditions because of immune response activation, this can be deleterious under normal growth conditions. Consistent with this, nasp-1 mutants showed compromised reproduction, like many other pathogen-resistant mutants (47) , indicating that the immune system might compete with the reproductive system for resources. Generally, chronic immune activation has been linked to several pathological disorders, like inflammatory bowel disease in humans (78) . Therefore, it is crucial to any organism to have mechanisms of innate immune suppression in the absence of pathogens.
On the basis of our results, we propose the following mechanism for the function of nasp-1 in the regulation of C. elegans innate immunity (Fig. 8F) . First, nasp-1 is a regulator of dcr-1. In nasp-1 mutants, dcr-1 function is repressed because of chromatin remodeling or related mechanisms, which leads to, besides RNAi deficiency, the inhibition of dcr-1-mediated miRNA processing. Consequently, certain miRNAs are not processed and, in turn, target genes, including col-92, are more strongly expressed than normal. As a consequence, mutant worms are more resistant to B. thuringiensis DB27 infection. Additionally, nasp-1, dcr-1, and drsh-1 mutants exhibit increased resistance to S. aureus as a secondary consequence of altered reproduction likely because of germ line defects. In general, germ line defects and fecundity might play a role in the observed resistance phenotypes of nasp-1 and dcr-1 mutants. It is important to note, however, that nasp-1 dcr-1 double mutants with cdc-25 RNAi gave different results for resistance to B. thuringiensis DB27 and S. aureus, respectively. These findings indicate complex interactions between fecundity and nematode immunity.
Given the comparative framework of our work, what about the specificity of nasp-1 and the resistance of P. pacificus to B. thuringiensis DB27? While nasp-1 is clearly conserved in sequence, the amino acid positions that are changed in the two C. elegans nasp-1 mutants are not. It is therefore possible that the exact molecular mechanisms of nasp-1 and its role in nematode immunity did change during the course of evolution. More generally, our parallel work on innate immunity in P. pacificus has recently revealed that more general anatomical and physiological parameters are in part responsible for the observed differences between the two species. P. pacificus is not equipped with a grinder, as is typical of members of the family Diplogastridae, and so does not lyse its bacterial food in the pharynx. P. pacificus mutants hypersusceptible to bacterial pathogens are often Unc mutants with an abnormal defecation cycle, indicating that the regulation of the defecation cycle is crucial for innate immunity (32) . Together, this comparative work on innate nematode immunity points toward the correlated action of anatomical, physiological, and molecular mechanisms that control nematode-bacterial interactions and regulate the evolution of innate nematode immunity.
